Jecko Thachil/LinkedIn
Mar 14, 2026, 15:40
Jecko Thachil: Anticoagulation in Patients With Metabolic-Associated Fatty Liver Disease
Jecko Thachil, Consultant Haematologist at NHS, shared a post on LinkedIn about about a recent article he and his colleagues co-authored, adding:
“Patients with liver disease were historically considered to be at increased risk of bleeding. But, now we know that such patients may actually be at increased risk of thrombosis, especially in setting of metabolic associated fatty liver disease or staetohepatitis.
How do we anticoagulate such patients?”
Title: The prothrombotic tendency of metabolic-associated fatty liver disease
Authors: Dawn Swan, Ton Lisman, Armando Tripodi, Jecko Thachil
Read the Full Article on Journal of Thrombosis and Haemostasis
Other posts featuring Jecko Thachil on Hemostasis Today.
-
Jun 23, 2026, 18:27Advancing Gene Therapy Research for Glanzmann Thrombasthenia – Glanzmann’s Research Foundation
-
Jun 23, 2026, 18:17What Every ITP Patient Wants to Know – ITP Support Association
-
Jun 23, 2026, 18:13Ahsan Fareed: Exploring Heart Failure Readmissions in Iron Deficiency Anemia
-
Jun 23, 2026, 18:09Swarnava Roy: Key Findings on Stress Erythropoiesis and Mitochondrial Retention in RBCs
-
Jun 23, 2026, 17:40Hossam El Benawi: How do We Predict Recurrence Post LVT Resoultion?
-
Jun 23, 2026, 17:39Nicolas Gendron: Do We Really Need All These Hemostasis Tests in Patients on DOACs?
-
Jun 23, 2026, 17:33Maité Mulkers: Time is Brain, and One Reason is That a Thrombus Develops Over Time
-
Jun 23, 2026, 17:32Dhargam Aljebouri: Honoured to Be Part of the Young Professionals Breakfast at ISBT 2026
-
Jun 23, 2026, 17:27Dianne E. van der Wal: Phenotype and Activation of the Endothelium in ET at ISTH 2026